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Vitamin C is reabsorbed from the renal lumen by one isoform
of sodium-vitamin C co-transporters that mediate high
affinity sodium-dependent L-ascorbic acid transport.
Sodium-vitamin C cotransporter-1 mRNA has been detected
in intestine and liver and the S3 segment of the renal
proximal tubule. Here, we found that its distribution was
broader and all three proximal tubule segments of
mouse and human expressed the transporter but the S3
segment had the highest expression. Sodium-vitamin C
co-transporter-1 expression was also found in the renal
epithelial-derived LLC-PK1 cell line. Ascorbic acid transport
in these cells was regulated by a single kinetic component
that depended on the sodium concentration, pH and
temperature. Reducing ascorbate concentration increased
the apical expression of the transporter suggesting the
presence of a feedback system for regulation of transporter
abundance at the luminal membrane.
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Vitamin C transport is essential in all mammalian cells. The
biological value of ascorbic acid (AA) rests in its ability to
serve as a reductant for ferric and cupric ions. Additionally,
ascorbate is involved in collagen, steroid, and neuropeptide
biosynthesis.1 As an aqueous-phase antioxidant concentrated
within the cell cytosol, vitamin C appears to play an
important role in protecting DNA from oxidative damage
linked to mutagenesis and the initiation of carcinogenesis.2
The ingested vitamin C is absorbed mainly in the
duodenum and proximal jejunum. For instance, in different
species, the absorption of L-ascorbate is linked to a pH-
dependent saturable active transport system that relies on the
presence of a carrier and sodium ions.3,4 L-ascorbate is
reabsorbed in the renal tubules in a similar manner using an
active and saturable process, an essential mechanism that
maintains homeostasis of circulating vitamin C.
Molecular cloning studies have identified two different
isoforms of high-affinity sodium-dependent vitamin C
co-transporters (SVCT1 and SVCT2).5–10 SVCT1 is a 604
amino acid protein mediating AA transport in the kidney,
intestine, and liver.5,6,8 SVCT2 is a 592 amino acid protein
that has been detected in brain cells (neurons, choroid plexus
cells, and cultured astrocytes) and different cells from
peripheral organs.7,8,11–14 SVCT1 functional expression has
been observed in rat kidney.15,16 Enhanced green fluorescence
protein-tagged SVCT1 expression showed apical distribution
in polarized cultures of kidney-derived Madin–Darby canine
kidney cells.17 Additionally, high expression of SVCT1 has
been demonstrated in the straight segment (S3) proximal
tubule by in situ hybridization,8 and further confirmed by
immunohistochemistry.18
Even though previous data suggest that vitamin C is
efficiently reabsorbed in the S3 segment, we hypothesized
that a resourceful AA absorption mechanism in the kidney
may also involve segments S1 and S2. In this study, we have
carried out a detailed experimental analysis of SVCT1
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expression (1) in the three separate segments of the renal
proximal tubule of mouse and human kidneys by optical and
ultrastructural immunohistochemistry and (2) by reverse
transcription-PCR (RT-PCR), immunoblotting, and func-
tional kinetic analyses in polarized LLC-PK1 cells.
RESULTS
SVCT1 distributes as a gradient of expression in the apical
domain of proximal tubule cells
We used a standard nomenclature to describe the gross
morphology of the kidney.19 The kidney cortex consists of
renal corpuscle, convoluted portions of the proximal and
distal tubules, and short lengths of the straight portions of
the tubules (Figure 1a, cortex). The medulla is divided into
an outer and an inner medulla; the outer medulla is further
divided into outer and inner stripes (Figure 1a). The medulla
consists of varying lengths of the straight portions of
proximal and distal tubules, the loops of Henle, collecting
ducts, as well as the vasa recta, which are unusually straight
blood vessels.
Using immunohistochemistry and in situ hybridization,
we carried out a detailed expression analysis of the SVCT1
transporter in the different cells and structures of the kidney
(Figure 1b and c). This approach showed that SVCT1
expression of both mRNA (Figure 1c and d) and protein
(Figure 1b, g, i, and j) was mainly associated with the straight
segment (S3) of proximal tubules located in the outer strip
of the outer medulla. However, SVCT1 expression was
also detected in the renal cortex by in situ hybridization
and immunohistochemical experiments (Figure 1e–g and k,
respectively). SVCT1 immunoreactivity was clearly concen-
trated in the apical region of the epithelial cells (Figure 1k,
arrows).
To obtain the precise localization of the transporter, we
increased the sensitivity of our immunodetection method by
performing immunostaining in 40-mm-thick free-floating
sections (Figure 2). A clear anti-SVCT1 immunoreaction was
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Figure 1 | Immunohistochemical detection and in situ
hybridization of SVCT1 mRNA expression in the adult mouse
kidney. (a) Schematic representation of adult kidney nephrons.
Histological sections of the adult mouse kidney were subjected
to immunohistochemistry using the specific anti-SVCT1 antisera
(b, g–k) and to in situ hybridization using a specific 657 bp
digoxigenin-labeled riboprobe for SVCT1 mRNA (c–f). High
expression of SVCT1 was observed in the proximal tubules
(S3 segment) present in the outer strip of the outer medulla
(c–d and g, i, and j), whereas low expression was detected in
segments S2 and S1 at the inner and outer cortex (e, f and g, k).
SVCT1 was specifically localized in the brush border of epithelial
proximal cells (i–k, arrows). Control experiments were performed
incubating the sections with antibodies pre-absorbed with an
excess of the peptide used for immunization (h). C, cortex; CT,
collecting tube; DCT, distal convoluted tubule; IS, inner stripe; IM,
inner medulla; M, medulla; OS, outer stripe; OM, outer medulla;
PCT, proximal convoluted tubule. Scale bars¼ 100 mm (b, c, and
g); 20mm (d–f, h–k).
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Figure 2 | Brush-border membrane polarization of SVCT1 in
the mouse kidney cortex and medulla. Thick floating
cryosections of mouse kidney cortex (a–c) and medulla (d–f)
were double stained with anti-SVCT1 (a, d, g, and h) and anti-
FBPase (b, e) antibodies and secondary antibodies conjugated to
Cy3 and Cy2, respectively. Merged images are shown in panels c
and f. SVCT1 was detected in the apical region of epithelial cells in
segments S3, S2, and S1, whereas FBPase only stained cells in
segments S1 and S2. OS, outer strip; OM, outer medulla. (g–h)
Pseudocolor images of SVCT1 immunostaining kidney cortex (g)
and medulla (h). (i) Semiquantitative analysis plot showing
relative fluorescence of SVCT1 immunocytochemical reaction in
the renal cortex and medulla. Scale bars¼ 20mm.
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visualized in the epithelial cells of the cortical proximal
tubules (Figure 2a). The tubule segments were identified on
the basis of their cellular structure and differential staining
for FBPase, an enzyme involved in glycolitic metabolism.
A similar sequence of expression was observed with anti-
SVCT1 (Figure 2a) and anti-FBPase (Figure 2b). In the inner
cortex, SVCT1 was expressed in segments S1 and S2, as
evidenced by positive FBPase staining (Figure 2a–f), whereas
straight tubules of the outer medulla (segment S3), with high
SVCT1-expression, were FBPase-negative (Figure 2d–f).
A semiquantitative analysis of the staining reaction was
obtained using confocal pseudocolor function, with yellow
and red depicting the highest intensity values based on color
scale (1500–2500) (Figure 2g and h). As shown in Figure 2i,
SVCT1 staining in the apical region of the tubule cells is
about 4.5 times higher in the medulla (segment S3) than in
the cortex.
To further characterize SVCT1 localization in the apical
domain of proximal cells of the cortex and outer medulla, we
carried out phaseolus vulgaris (PHA) lectin histochemical
analysis. This lectin displays an elevated affinity for sugar
moieties concentrated in the apical brush border of straight
proximal tubules; however, it binds also to the brush border
of convoluted proximal tubules. As shown in Figure 3,
SVCT1 transporter showed an extensive colocalization with
PHA lectin in the brush border of cortical and medullary
proximal cells (Figure 3d–i). However, in the glomerulus,
reduced binding of PHA lectin was associated with an
absence of SVCT1 staining (Figure 3f, asterisk). By viewing
the ultrastructural images, we confirmed that SVCT1 is
distributed within the apical brush border of proximal
tubules of the outer medulla (Figure 4a and b); however, we
were unable to observe the transporter in the cortical region.
In the human kidney, an intense signal of the immuno-
labeled SVCT1 was visualized in the brush border of proximal
tubules situated in the medullary rays and cortex (Figure 5a,
d and e). Even though a high intensity for SVCT1 was
detected in straight proximal tubules of the outer medulla
(Figure 5e, inset), the immunostaining of cortical proximal
tubules was higher than that observed in the mouse (Figure
5b and c). The glomerulus and distal convoluted tubules
remained unstained for SVCT1 (Figure 5b and c).
Kinetic characterization of the AA transport in LLC-PK1 cells
To determine the physiological importance and function of
SVCT1 transporter in renal proximal tubule epithelial cells, a
series of in vitro experiments were conducted using the LLC-
PK1 kidney-derived cell line. RT-PCR and western blot
analyses demonstrated the expression of SVCT1 in this cell
line (Figure 6a and b). Mouse kidney extracts were used for
positive controls (Figure 6a and b). Immunocytochemistry
showed that SVCT1 was mainly distributed intracellularly in
pre-confluent LLC-PK1 cells (Figure 6c); however, in post-
confluent cultures, endogenous SVCT1 transporter was
detected within the apical domain (Figure 6d). Considering
this, post-confluent LLC-PK1 cell cultures were used to carry
out a detailed kinetic characterization of AA transport. The
transport was linear for the first 30 min (Figure 7a), with an
initial uptake velocity of 20±3 pmol 106 cells per min. The
total AA uptake after 30 min was 440±45 pmol per 106 cells
(Figure 7a). Dose-response studies using 5 min assays
revealed that AA transport was saturated at concentrations
above 250 mM (Figure 7c). Data analysis suggested the
presence of one kinetic component for ascorbate transport.
The Eadie–Hofstee transformation showed an apparent Km of
180 mM and a maximum velocity (Vmax) of 12±3 pmol 106
cells per min (Figure 7d). To test the sodium dependence of
AA transport, we replaced NaCl with choline chloride in the
assay. Transport of AA by LLC-PK1 cells was decreased by at
least 90% in the absence of sodium and the uptake reached a
plateau of 40±2 pmol per 106 cells after 20 min (Figure 7a).
These data strongly suggest that vitamin C is incorporated
into LLC-PK1 cells using an SVCT-like transporter. Further-
more, inhibition experiments revealed that cytochalasin B
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Figure 3 | Colocalization of SVCT1 and PHA lectin binding in
the mouse adult kidney. Thick floating cryosections of the
mouse kidney were stained with PHA lectin (a, d, and g) and
immunostained with anti-SVCT1 antibody and a secondary
Cy3-conjugated antibody (b, e, and h). Merged images are shown
in panels c, f, and i. Low-magnification images (a–c) show strong
SVCT1 and PHA lectin staining in the outer stripe (OS) of the outer
medulla (OM); however, high-magnification images show
extensive colocalization of PHA lectin and SVCT1 in the brush
border of proximal tubules at the cortex (d–f, arrows) and at the
OS of the OM (g–i, arrows). IS/OM, inner stripe of the outer
medulla. Asterisk (*), glomerulus. Scale bars¼ 50mm (a–c);
12mm (d–i).
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failed to affect AA transport, indicating that the transporters
expressed by LLC-PK1 cells are functionally unrelated to the
dehydroascorbic acid transporters. However, ouabain at a
concentration of 20 mM inhibited transport by 50%; a similar
effect was observed when we replaced the NaCl with choline
chloride (Figure 7b). These results strongly suggest that AA is
co-transported with sodium ions in LLC-PK1 cells. Analysis
of sodium ion effect on AA transport at 100 mM AA revealed
that this transporter was strongly activated by sodium in a
cooperative fashion, as indicated by the slightly sigmoidal
shape of the concentration/velocity curve (Figure 7e). This
conclusion was corroborated by the Hill plot of the data,
which displays a straight line with a slope (Hill coefficient) of
3.1 (Figure 7f). When the effect of temperature in the uptake
of AA was analyzed, we observed that transport was almost at
basal levels at 4 1C, but when temperature raised to 22 1C, the
velocity of transport increased to 58±3 pmol 106 cells per
min (Figure 7g). AA transport was almost three times higher
than that recorded at 4 1C when the uptake was carried out at
37 1C (145±45 pmol 106 cells per min) (Figure 7g). Finally,
we observed that AA uptake was also regulated by pH
(Figure 7h).
Figure 4 | Ultrastructural immunogold labeling of SVCT1 in
proximal epithelial cells of the mouse kidney. (a) Proximal
tubule cells (apical region) observed with low magnification.
(b) Brush-border membrane observed with high magnification.
Arrows indicate gold particles on the microvilli. Original
magnification were (a)  17,000; (b)  35,000.
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Figure 5 | Immunohistochemical detection of SVCT1
expression in the adult human kidney. Histological sections of
the adult human kidney were subjected to immunohistochemistry
using the specific anti-SVCT1 antisera and a peroxidase-
conjugated secondary antibody. (a) A low-magnification image
shows intense immunostaining for SVCT1 in the proximal tubules
situated in the medullary ray (MR) and cortex. High-magnification
images show that SVCT1 immunostaining is strongly concentrated
at the brush-border membrane of epithelial cells of the proximal
convoluted (b–d) and straight (e) tubules and MRs (d, e).
Low-to-absent expression was detected in the cells of the distal
convoluted tubes (DCT). PCT, proximal convoluted tubule; PST,
proximal straight tubule; G, glomerulus. Scale bars¼ 20mm (a–e).
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Figure 6 | RT-PCR, western blot, and immunocytochemistry for
SVCT1 in LLC-PK1 cells. (a) mRNAs isolated from adult human
(lane 1) and mouse (lane 2) kidneys as well as from LLC-PK1 cells
(lane 3) were subjected to RT-PCR with specific primers against
SVCT1 transporter. Lane 4, reverse transcriptase-negative reaction
for LLC-PK1 cells mRNA. As controls, RT-PCRs were performed
with specific primers against b-actin (lower panel). Arrows in the
right of each panel indicate the expected RT-PCR product size for
mouse SVCT1 (439 bp) and b-actin (333 bp). (b) Western blot
analysis using specific anti-SVCT1 antibodies detected a 68 kDa
band in membrane protein extracts from the mouse kidney and
LLC-PK1 cells (lanes 1 and 2, respectively). As controls, western
blots were developed avoiding primary antibodies (lane 3).
(c) Immunocytochemical analysis of SVCT1 (green) in
pre-confluent (c) and post-confluent (d) LLC-PK1 cells. Cell nuclei
in panel c were stained with propidium iodide. Inset in panel c
shows negative controls and primary antibodies were avoided.
Lower (x–z) panel in panel d show confocal z-sections of the plane
indicated with white line in panel d. Scale bar¼ 20mm.
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AA regulates SVCT1 apical distribution and uptake in
LLC-PK1 cells
Our results revealed a gradient of expression for SVCT1 in
the apical domain of proximal tubules. On the basis of this
observation we hypothesized that this pattern of expression
may be regulated through changes in local concentrations of
ascorbate. Thus, the increasing gradient of SVCT1 expression
toward distal regions of the proximal tubule could correlate
with an inverted decreasing gradient of ascorbate. To
experimentally test this concept, we examined the expression
of SVCT1 in post-confluent LLC-PK1 cells that were
previously incubated with increasing concentrations of AA.
As a control, we used LLC-PK1 cells cultured with a low AA
concentration known to be present in the serum added to the
culture medium. Confocal z-sections showed that the strong
apical pattern of SVCT1 expression, observed under control
conditions, dropped off in parallel with the increase in
ascorbate used to pretreat the cells (Figure 8a). Additionally,
we performed transport assays in LLC-PK1 cells exposed to
AA. Consistent with our immunolabeling data, the uptake of
100 mM 14C-AA was reduced by 50% on cells pretreated with
high concentrations (50–100 mM) of AA (Figure 8b). These
results show that LLC-PK1 cells displaying a reduced apical
distribution of SVCT1, still retain the capacity to transport
AA. To further analyze the extent to which these cells
efficiently transport AA, the uptake of increasing concentra-
tions of AA was studied in cells pretreated with increasing AA
concentrations (Figure 9). Our results show that cells
pretreated with 100 mM AA are able to transport significantly
more 14C-AA than cells having comparatively more SVCT1 in
their apical membrane, a condition induced by incubating
the cells with a low AA concentration (C and 10–25 mM)
(Figure 9). These results suggest that despite changes in the
apical distribution of SVCT1 in LLC-PK1 cells, the uptake of
AA is driven by the availability of 14C-AA in the extracellular
space.
DISCUSSION
Previous reports have shown that the mRNA for the
sodium–vitamin C co-transporter SVCT1 is expressed in
epithelial absorptive cells of the intestine, kidney, and
liver,5,6,8 as well as in primary cultures and cell lines derived
from these tissues.20–22 After in situ hybridization and
immunolabeling experiments, we demonstrated that SVCT1
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Figure 7 | Kinetic analysis of L-ascorbate uptake in LLC-PK1 cells. (a) Time course of 50mM AA uptake at 37 1C in the presence of NaCl
(open circles) or replacing NaCl with choline chloride (solid circles). (b) Uptake at 10 min of 50 mM AA in LLC-PK1 cells that were treated
with choline chloride, 10 mM ouabain for 1 h, and 25 mM cytochalasin B for 10 min. Results are expressed as percentage of the control
(*Po0.001). (c) Dose-response curve of L-ascorbic acid at 37 1C. (d) Eadie–Hofstee transformation of the data in panel c. (e) Velocity of 50mM
AA uptake at 10 min as a function of the concentration of extracellular sodium at 37 1C. (f) Hill plot of the data in panel e. (g) Uptake of 50 mM
AA at 5 min between 4 and 37 1C. (h) pH dependence of 50 mM AA uptake at 5 min. Data represent the mean±s.d. of at least two
experiments performed in triplicate.
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is preferentially expressed in proximal tubules of the outer
strip of the external medulla, specifically in the S3 segment.
These results are consistent with the previous work showing
the expression of SVCT1 mRNA in rat kidney tissue,9 isolated
chick proximal tubules, and cultured cells22 and SVCT1 by
immunolabeling experiments in the mouse kidney.18 None-
theless, our detailed analysis of SVCT1 distribution showed
that this transporter is not restricted to the S3 segment, but it
is expressed all along the proximal tubule where it can be
visualized as a gradient of expression. Indeed, semiquantita-
tive data obtained by confocal pseudocolor function showed
that the levels of expression of SVCT1 in the outer strip of the
outer medulla were about 4.5-fold higher than in the cortex.
The localization of SVCT1 at segments S1 and S2 present in
the inner cortex was further confirmed in thick floating
sections stained for FBPase. In these experiments, epithelial
cells at the S3 segment showed high SVCT1 expression, but
no reactivity for FBPase. Interestingly, a similar SVCT1
distribution was expressed in the adult human kidney.
SVCT1 localization in the brush border of proximal tubules
followed the gradient of expression similar to that observed
in the mouse kidney. These results suggest a conserved
mechanism of vitamin C absorption in the kidney.
In experiments to determine the precise cellular expres-
sion, SVCT1 was visualized in the brush-border membrane of
mouse and human kidney absorptive cells. The specific
subcellular localization of SVCT1 was confirmed using
the PHA lectin as a marker of the apical domain and
ultrastructural immunocytochemistry. In both cases, SVCT1
immunoreactivity was localized within the brush-border
membrane and the apical domain of proximal epithelial cells,
suggesting that SVCT1 reabsorps AA from the glomerular
filtrate. Previous work, using isolated proximal tubules, have
demonstrated that immunoreactivity of SVCT118 and AA
transport22 is restricted to the apical membrane. Also,
enhanced green fluorescence protein-tagged constructs of
SVCT1 have been shown to be confined to the apical
domain.17
To analyze the kinetic behavior of SVCT1 we used LLC-
PK1 cells, an epithelial cell line derived from pig proximal
tubule cells that expresses SVCT1,5 an observation that we
confirmed through RT-PCR and western blot analyses.
Similar to its distribution in vivo, post-confluent LLC-PK1
cell cultures distributed SVCT1 within the apical domain,
suggesting that these cells are an appropriate in vitro model
to study renal SVCT1 function. Ascorbate dose-response
curves showed a Michaelis–Menten curve, whereas the
Eadie–Hofstee transformation showed one kinetic compo-
nent with an apparent Km of 180 mM. These results
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Figure 8 | SVCT1 detection and function in LLC-PK1 cells
treated with different ascorbic acid concentration.
(a) Immunocytochemical analysis of SVCT1 in post-confluent LLC-
PK1 cells incubated with different concentrations of AA (C, 10, 25,
50, and 100 mM). Lower panel (x–z) show confocal z-sections of the
planes indicated with white lines. (b) Uptake at 10 min of 100 mM
AA in LLC-PK1 cells that were treated with different
concentrations of the vitamin. As a control (c), we used LLC-PK1
cells cultured with a low AA concentration (probably lesser than
10mM) present in the serum added to the culture medium. Data
represent the mean±s.d. of at least two experiments performed
in triplicate. Scale bar¼ 10mm (a).
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Figure 9 | L-Ascorbic acid uptake in LLC-PK1 cells pretreated
and incubated with different concentrations of vitamin C.
LLC-PK1 cells were cultured with 10, 25, 50, and 100 mM AA and
the vitamin C uptake was performed using the same
concentration in each point. As a control (C), we incubated
LLC-PK1 cells with a low AA concentration (probably lesser than
10mM) present in the serum added to the culture medium. Data
represent the mean±s.d. of at least two experiments performed
in triplicate.
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corresponded with Km values obtained when human SVCT1
was overexpressed in COS-1 cells23 and in mRNA micro-
injection studies in Xenopus laevis oocytes.9,10 Moreover,
comparable Km values were obtained for the incorporation of
AA into vesicles derived from the apical membrane of
proximal tubules.15,24 Our kinetic analyses also showed that
ascorbate transport is activated by the presence of sodium in
the assay medium. Ouabain inhibition decreased ascorbate
transport velocity by about 50%, which correlates with data
obtained from Xenopus oocytes microinjected with human
SVCT1 mRNA8 and from CHO and Madin–Darby canine
kidney cells overexpressing human SVCT1.17 Additionally, we
demonstrated that the velocity of ascorbate uptake is directly
affected by the temperature and the pH.
The expression of SVCT1 in epithelial cells of renal
proximal tubules is consistent with the function of these
structures in the sodium-dependent clearance of different
biomolecules. We reasoned that most of the AA in the
glomerular filtrate is reabsorbed at the segment S1, as it is
well known for sodium ions and other solutes. Thus, our
observation that SVCT1 is expressed in an increasing gradient
toward distal regions of the proximal tubule (from S1 to S3
segments) could be linked with an inverted decreasing
gradient of ascorbate. Of particular interest in this regard,
is the fact that intestinal epithelial cells exposed to high
concentrations of ascorbate display reduced SVCT1 expres-
sion.21 To analyze whether such a mechanism regulates
SVCT1 expression and function in renal proximal tubules, we
incubated post-confluent LLC-PK1 cells with different
concentrations of AA. Our data show that preincubation
with high concentrations of AA results in diminished apical
distribution of SVCT1 and AA uptake. On the basis of these
results, we speculated that epithelial cells at the S3 segment
upregulate SVCT1 expression to reabsorb efficiently the
comparative low concentration of AA present in this region.
As an in vitro approach to test this idea, we studied the uptake
of increasing concentrations of AA in cells displaying
decreasing apical distribution of SVCT1. Our data show that
control LLC-PK1 cells uptake comparatively less AA than cells
having decreased apical distribution of SVCT1. In the context
of our previous data, these results suggest that the low affinity
of SVCT1 for AA is not compensated by the upregulation of
the transporter in the apical membrane of cells.
In conclusion, SVCT1 is expressed in the apical brush-
border membrane of the epithelial cells throughout segments
S1–S3 of proximal tubules of both human and mouse
kidneys. Our kinetic data led us to conclude that SVCT1 is a
functional transporter for AA uptake in kidney epithelium-
derived LLC-PK1 cells. Finally, we postulate that AA regulates
the apical membrane distribution of SVCT1 in polarized
LLC-PK1 cells.
MATERIALS AND METHODS
Animals and experimental procedures
The Universidad de Concepcion Ethics Committee approved all
experimental procedures carried out during this study. Healthy male
normotensive C57BL/J6 mice (aged 6–12 weeks, weighing 32±3 g)
were obtained from our University Breeding Center. Animals were
maintained on a 12-h light–dark cycle at constant room temperature
with free access to normal sodium rat chow and water.
Immunohistochemistry
Mouse kidneys were dissected and fixed directly by immersion in
Bouin’s solution, or fixed in situ by vascular perfusion.25 Samples
were dehydrated in graded alcohol solutions and embedded in
paraffin. Sections (5 mm) were obtained and mounted on poly-L-
lysine-coated glass slides. Before immunostaining, the sections were
treated with absolute methanol and 3% hydrogen peroxide to
inactivate endogenous peroxidase activity.26 We used anti-SVCT1
antibodies raised against a synthetic peptide from human and rat
sodium–vitamin C co-transporters (Santa Cruz Biotechnology,
Santa Cruz, CA, USA). Anti-SVCT1 (D-19) was used to analyze
samples from mouse and rat tissues. Anti-SVCT1 (N-20) was used
to analyze samples from human tissues. Anti-SVCT1 (C-15) was
used to analyze samples isolated from LLC-PK1 cells. Sections were
incubated with anti-SVCT1 polyclonal antibody (1:100) overnight at
room temperature in a humid chamber. For double labeling, we also
used anti-FBPase (1:100), an antibody that recognizes the gluconeo-
genic enzyme fructose-1-6-bisphosphatase. The immunohistochemi-
stry technique has been previously described.27 Alternatively, after
incubation with the primary antibody, some slides were incubated
for 2 h at room temperature with Cy2- or Cy3-conjugated secondary
antibodies (1:200; Jackson ImmunoResearch, West Grove, PA, USA)
and analyzed by confocal laser microscopy.28 For double labeling, we
used 25 mg/ml Alexa 488-labeled PHA lectin (Molecular Probes,
Eugene, OR, USA). As controls, we used both primary antibodies
pre-absorbed with an excess of the cognate peptides used for
immunization or preimmune serum.
Ultrastructural immunohistochemistry
Mouse kidney tissues were immersed for 2 h in fixative containing
2% paraformaldehyde, 0.5% glutaraldehyde in 0.1 M phosphate
buffer, and pH 7.4. The samples were dehydrated in dimethylfor-
mamide and embedded in London Resin Gold (Electron Micro-
scopy Science, Washington, DC, USA). Ultrathin sections were
mounted on uncoated nickel grids and processed for immunohis-
tochemistry.27 The anti-SVCT1 antibody (1:100) was diluted in
incubation buffer Tris-HCl (pH 7.8).29
In situ hybridization
A cDNA of approximately 0.6 kb subcloned in pCR-4-Blunt-TOPO
and encoding a human SVCT1 fragment was used to generate sense
and antisense digoxigenin-labeled riboprobes. The human probe for
SVCT1 used for in situ hybridization has high-sequence homology
with mouse SVCT1 (87%). RNA probes were labeled with
digoxigenin-UTP by in vitro transcription with SP6 or T7 RNA
polymerase following the manufacturer’s procedure (Boehringer
Mannheim, Mannheim, Germany). In situ hybridization was
performed on mouse sagital kidney sections mounted on poly-L-
lysine-coated glass slides. The hybridization methodology has been
previously described.29 After hybridization, the slides were rinsed in
4 saline-sodium citrate (SSC) and washed twice for 30 min at
42 1C. The slides were washed at 37 1C for 30 min each in 2 SSC,
1 SSC, and 0.3 SSC. Visualization of digoxigenin was
performed by incubation with a monoclonal antibody coupled to
alkaline phosphatase.29
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Reverse transcription-PCR
The following samples were used for RT-PCR analysis: (i) cortical
and medullar kidney regions of adult C57BL/J6 mice; (ii) mRNA
from adult human kidney (Clontech, Palo Alto, CA, USA); and
(iii) mRNA from LLC-PK1 cells. The poly(A) RNA was isolated
using the Oligotex direct kit (Qiagen, Valencia, CA, USA). For RT-
PCR, 0.5–1 mg of RNA was incubated in 20 ml reaction volume
containing 10 mM Tris (pH 8.3), 50 mM KCl, 5 mM MgCl2, RNase
inhibitor 20 U, 1 mM dNTPs, 2.5 mM of random hexanucleotides, and
50 U of MuLV reverse transcriptase (Perkin Elmer, Branchburg, NJ,
USA) for 10 min at 23 1C, followed by 30 min at 42 1C and 5 min at
94 1C. Parallel reactions were performed in the absence of reverse
transcriptase to control for the presence of contaminant DNA. For
amplification, a cDNA aliquot in a volume of 12 ml containing
20 mM Tris, pH 8.4, 50 mM KCl, 1.6 mM MgCl2, 0.4 mM dNTPs,
0.04 U of Taq DNA polymerase (Gibco-BRL, Rockville, MD, USA),
and 0.4 mM primers was incubated at 94 1C for 4 min, 94 1C for 50 s,
55 1C for 50 s, and 72 1C for 135 s for 35 cycles. PCR products were
separated by 1.2% agarose gel electrophoresis and visualized by
staining with ethidium bromide. The following primers (based on
human sequence AF170911) were used to analyze the expression of
SVCT1-like transporter: forward primer, 50-TGGTTCCAGCCAAA
GCCATAC-30 and reverse primer, 50-ATGGCCAGCATGATAGGA
AA-30 (expected product 439 bp).
Cell culture
LLC-PK1 cells were grown in Dulbecco’s modified Eagle medium
supplemented with 10% fetal bovine serum, penicillin, and
streptomycin. For immunocytochemistry, pre- or post-confluent
cells were fixed in 4% paraformaldehyde diluted in phosphate-
buffered saline for 30 min.
Western blot
LLC-PK1 and mouse kidney membrane proteins were obtained by
homogenizing the cells in 0.3 mM sucrose, 3 mM dithiothreitol, 1 mM
EDTA, 100mg/ml phenylmethanesulfonylfluoride, pepstatin A 1 mg/
ml, and aprotinin 2 mg/ml. Total membranes were collected by high-
speed centrifugation. For immunoblotting, 30 mg of membrane
protein was loaded in each lane and fractionated by polyacrylamide
gel electrophoresis in the presence of sodium dodecyl sulfate,
transferred to nitrocellulose membranes, and probed against anti-
SVCT1 antibodies or pre-absorbed antibodies (1:100–1:500).30 The
secondary antibody was rabbit anti-goat IgG coupled to peroxidase
(1:5000). The reaction was developed with enhanced chemilumines-
cence according to the ECL western blotting analysis system
(Amersham Corporation, Arlington Heights, IL, USA).
Vitamin C uptake analyses
LLC-PK1 cells were carefully selected under the microscope to
ensure that only plates showing uniformly growing cells were used at
200,000 cells per well. The cells were incubated in buffer containing
15 mM HEPES (N-2-hydroxyethylpiperazine-N0-2-ethanesulfonic
acid), 135 mM NaCl, 5 mM KCl, 1.8 mM CaCl2, and 0.8 mM MgCl2
at room temperature for 30 min. Uptake assays were performed in
500ml of incubation buffer containing 0.1–0.4 mCi of 1-14C-AA
(specific activity 8.2 mCi/mmol) to a final concentration of
5–300mM. The Michaelis constant, Km, was calculated using the
Lineweaver–Burk analysis. Data represent means±s.d. of three
experiments with each determination performed in duplicate. In
inhibition experiments, statistical comparison between two or more
groups of data was carried out using analysis of variance (followed
by Bonferroni post-test). Po0.05 was considered to be statistically
significant. To analyze the effect of AA on SVCT1 expression and
function, post-confluent LLC-PK1 cells were treated with 10, 25, 50,
and 100mM AA for 96 h by replacing with fresh media containing
1 mm dithiothreitol every 12 h. Initial velocity transport assays
were performed after 10-min incubation with different 1-14C-AA
concentrations.
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